Vascular Disease

Stephen Kopecky, MD, on CV Biomarkers, Anticoagulation Management in AFib, and More

09/25/2018

 

 

Dr Stephen Kopecky from Mayo Clinic talks about his 3 sessions at the ASPC's 2018 Congress: cardiovascular disease biomarkers, lipid testing, managing atrial fibrillation with anticoagulation therapy, and the effect of testosterone therapy on cardiovascular events.

 

Stephen L. Kopecky, MD, is a professor of medicine and consultant in cardiovascular diseases and internal medicine at Mayo Clinic in Rochester, Minnesota.

 

 

References:

 

Yeboah J, Young R, McClelland RL, et al. Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. J Am Coll Cardiol. 2016;67(2):139-147. doi:10.1016/j.jacc.2015.10.058.

 

Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation. 2009;119(7):931-939. https://doi.org/10.1161/CIRCULATIONAHA.108.816181. 

 

Kavousi M, Elias-Smale S, Rutten JH, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 2012;156(6):438-444. doi:10.7326/0003-4819-156-6-201203200-00006.

 

January CT, Wann LS, Alpert JS, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1-76. doi:10.1016/j.jacc.2014.03.022.

 

Kloner RA, Carson C, Dobs A, Kopecky S, Mohler ER. Testosterone and cardiovascular disease. J Am Coll Cardiol. 2016;67(5):545-557. doi:10.1016/j.jacc.2015.12.005.

 

Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011;171(20):1797-1803. doi:10.1001/archinternmed.2011.440.

 

 

 

Related Content

Adrenal Disorders
Adrenal Disorders
Phyllis Speiser, MD, on the Endocrine Society’s Guideline for CAH Due to Steroid 21-Hydroxylase Deficiency
01/22/2020
Dr Speiser answers our questions about the Endocrine Society’s 2018 clinical practice guideline for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency.
01/22/2020
Stress and Burnout
Pepper, Fan
Stress and Burnout
Expert Conversations: Management of ARDS in the Era of COVID-19
05/27/2020
In this podcast, Dominique Pepper, MD, interviews Eddy Fan, MD, PhD, about the diagnosis and management of acute respiratory distress syndrome in the era of COVID-19.
05/27/2020
Infectious Diseases
Infectious Diseases
Daniel Eiras, MD, on How COVID-19 Has Affected My STD/HIV Practice in NYC
04/07/2020
In this podcast, Infectious Diseases Consultant Advisory Board Member Daniel Eiras, MD, discusses his experience with treating patients in New York City amid the COVID-19 pandemic, and how the pandemic has...
04/07/2020
Gastroenterology
Gastroenterology
Jamie Koufman, MD, on Lean, Green, Clean, and Alkaline: A Lifestyle to Cure Reflux
10/05/2017
Jamie Koufman, MD, from The Voice Institute of New York, talks to us about nutrition, acid reflux, and the future of nutrition in the United States.
10/05/2017
decision-making
decision-making
Claire Barber, MD, on Using Patient Aids for Rheumatoid Arthritis Care
05/19/2021
Dr Barber discusses the lessons learned from her research into the use of patient aids and shared decision making among patients with rheumatoid arthritis and their health care providers.
05/19/2021